Pharmagen, Inc. (PHRX)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026
0.00%
Market Cap 517.00
Revenue (ttm) 4.41M
Net Income (ttm) -6.43M
Shares Out 517.08M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Average Volume 16,718
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0000
Beta 0.24
RSI 51.03
Earnings Date n/a

About Pharmagen

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology,... [Read more]

Sector Healthcare
Employees 24
Stock Exchange OTCMKTS
Ticker Symbol PHRX
Full Company Profile

Financial Performance

In 2013, Pharmagen's revenue was $4.81 million, an increase of 12.97% compared to the previous year's $4.26 million. Losses were -$6.46 million, 133.0% more than in 2012.

Financial Statements

News

There is no news available yet.